Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STIM1 | Q13586 | 8/20 | 0.85 |
| ▸ | ORAI1 | Q96D31 | 8/20 | 0.85 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.52 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | DAGLB | Q8NCG7 | 1/20 | 0.49 |
| ▸ | GPR142 | Q7Z601 | 1/20 | 0.48 |
| ▸ | SNCA | P37840 | 1/20 | 0.46 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.46 |
| ▸ | STS | P08842 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | LDHA | P00338 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26628306 | 1.00 | STIM1 (0.85) | STIM1ORAI1KEAP1NFE2L2CA12 | |
| SCHEMBL29946234 | 0.92 | STIM1 (1.00) | STIM1ORAI1KEAP1NFE2L2CA12 | |
| SCHEMBL26628321 | 0.92 | STIM1 (1.00) | STIM1ORAI1KEAP1NFE2L2CA12 | |
| SCHEMBL29946140 | 0.92 | STIM1 (0.77) | STIM1ORAI1KEAP1NFE2L2CA12 | |
| SCHEMBL26628278 | 0.92 | STIM1 (0.77) | STIM1ORAI1KEAP1NFE2L2CA12 | |
| SCHEMBL1430051 | 0.90 | STIM1 (0.80) | STIM1ORAI1KEAP1NFE2L2CA12 | |
| SCHEMBL26628283 | 0.89 | STIM1 (0.85) | STIM1ORAI1KEAP1NFE2L2MAOA | |
| SCHEMBL29946183 | 0.89 | STIM1 (0.85) | STIM1ORAI1KEAP1NFE2L2MAOA | |
| SCHEMBL29946155 | 0.87 | STIM1 (1.00) | STIM1ORAI1KEAP1NFE2L2CA12 | |
| SCHEMBL26628301 | 0.87 | STIM1 (1.00) | STIM1ORAI1KEAP1NFE2L2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4106871-A1 | BIPHENYL COMPOUNDS AS SOCE MODULATORS, COMPOSITIONS AND USES THEREOF | Università degli Studi del Piemonte Orientale "Amedeo Avogadro" (IT) | 2022-12-28 | — | — | EP | claimed |
| CN-115243765-A | Biphenyl compounds as SOCE modulators, compositions and uses thereof | 皮埃蒙特阿米阿伏伽德罗东方大学 | 2022-10-25 | — | — | CN | claimed |
| US-20230348404-A1 | BIPHENYL COMPOUNDS AS SOCE MODULATORS, COMPOSITIONS AND USES THEREOF | UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE "AMEDEO AVOGADRO" (IT) | 2023-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348404-A1 | BIPHENYL COMPOUNDS AS SOCE MODULATORS, COMPOSITIONS AND USES THEREOF | ORAI1, SARAF, STIM1 | STIM1 3/4885ORAI1 1/4885KEAP1 1857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.